Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsAndrew J. Hirsch is recorded as CEO at C4 Therapeutics, Inc. (CCCC). The newest filing on record that lists Andrew J. Hirsch as CEO at C4 Therapeutics, Inc. (CCCC) is dated April 29, 2026. The proxy statement of C4 Therapeutics, Inc. reports total compensation of $2,940,975 for Andrew J. Hirsch in fiscal 2025, including a base salary of $694,925. Disclosed compensation is on record for 7 fiscal years. Andrew J. Hirsch has spoken on 4 investor events across 1 company, most recently for C4 Therapeutics, Inc. on November 9, 2026. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member), Kendra R. Adams (CFO and Chief Accounting Officer) and 7 others.
“So first, for those of you who are unfamiliar, simcinimide, it's a cereblon-modulating protein degrader of two transcriptor factors, IKZF1-3, which are critical in multiple myeloma.”
“So the last 12 months have actually been quite exciting for myeloma patients in general and the field.”
“As you know, C4 Therapeutics is a leading clinical-stage biopharmaceutical company advancing the novel modality of targeted protein degradation to treat patients with cancer as well as inflammatory, neuroinflammatory, and neurodegenerative diseases.”
“We're really excited to share what we're working on at C4. Obviously the, you know, our new program, is front and center, especially in the wake of some of the exciting data in the space coming out of Aska.”
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $694,925 | $2,940,975 |
| 2024 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $665,000 | $5,239,784 |
| 2023 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $639,000 | $3,790,099 |
| 2022 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $614,400 | $2,595,395 |
| 2021 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $579,600 | $952,200 |
| 2020 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | $167,850 | $20,931,971 |
| 2019 | C4 Therapeutics, Inc. (CCCC) | President & Chief Executive Officer | — | — |
